METTL3 and nasopharyngeal carcinoma: Instead, it competed with USP5 for binding to the mTase domain of METTL3 (Figure 3G-I), thereby inhibiting METTL3's binding to USP5 and reducing the protein stability of METTL3 in NPC cells.